Literature DB >> 21622291

Chemokines: key players in cancer progression and metastasis.

Rajesh Singh1, James W Lillard, Shailesh Singh.   

Abstract

Instructed cell migration is a fundamental component of various biological systems and is critical to the pathogenesis of many diseases including cancer. Role of chemokines in providing navigational cues to migrating cancer cells bearing specific receptors is well established. However, functional mechanisms of chemokine are not well implicit, which is crucial for designing new therapeutics to control tumor growth and metastasis. Multiple functions and mode of actions have been advocated for chemokines and their receptors in the progression of primary and secondary tumors. In this review, we have discussed current advances in understanding the role of the chemokines and their corresponding receptor in tumor progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622291      PMCID: PMC3760587          DOI: 10.2741/246

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  113 in total

Review 1.  The IGF system and breast cancer.

Authors:  D Sachdev; D Yee
Journal:  Endocr Relat Cancer       Date:  2001-09       Impact factor: 5.678

2.  NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.

Authors:  Gregory Helbig; Kent W Christopherson; Poornima Bhat-Nakshatri; Suresh Kumar; Hiromitsu Kishimoto; Kathy D Miller; Hal E Broxmeyer; Harikrishna Nakshatri
Journal:  J Biol Chem       Date:  2003-04-09       Impact factor: 5.157

Review 3.  Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica
Journal:  Eur J Cancer       Date:  2004-07       Impact factor: 9.162

4.  Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.

Authors:  Hiroaki Kajiyama; Kiyosumi Shibata; Mikio Terauchi; Kazuhiko Ino; Akihiro Nawa; Fumitaka Kikkawa
Journal:  Int J Cancer       Date:  2008-01-01       Impact factor: 7.396

5.  Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.

Authors:  G Luboshits; S Shina; O Kaplan; S Engelberg; D Nass; B Lifshitz-Mercer; S Chaitchik; I Keydar; A Ben-Baruch
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

6.  Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Authors:  Chris J Scotton; Julia L Wilson; Kate Scott; Gordon Stamp; George D Wilbanks; Simon Fricker; Gary Bridger; Frances R Balkwill
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

Review 7.  Lymphocyte traffic control by chemokines.

Authors:  B Moser; P Loetscher
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

Review 8.  The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.

Authors:  T N Hartmann; M Burger; J A Burger
Journal:  J Biol Regul Homeost Agents       Date:  2004 Apr-Jun       Impact factor: 1.711

9.  CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia.

Authors:  Bernd C Schmid; Margarethe Rudas; Günther A Rezniczek; Sepp Leodolter; Robert Zeillinger
Journal:  Breast Cancer Res Treat       Date:  2004-04       Impact factor: 4.872

10.  The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.

Authors:  Yi-fang Ping; Xiao-hong Yao; Jian-hong Chen; Hong Liu; Dai-lun Chen; Xiang-dong Zhou; Ji Ming Wang; Xiu-wu Bian
Journal:  J Neurooncol       Date:  2007-04-06       Impact factor: 4.506

View more
  24 in total

Review 1.  CXCR3 in carcinoma progression.

Authors:  Bo Ma; Ahmad Khazali; Alan Wells
Journal:  Histol Histopathol       Date:  2015-02-09       Impact factor: 2.303

2.  Multi-marker analysis of genomic annotation on gastric cancer GWAS data from Chinese populations.

Authors:  Fei Yu; Tian Tian; Bin Deng; Tianpei Wang; Qi Qi; Meng Zhu; Caiwang Yan; Hui Ding; Jinchen Wang; Juncheng Dai; Hongxia Ma; Yanbing Ding; Guangfu Jin
Journal:  Gastric Cancer       Date:  2018-06-01       Impact factor: 7.370

3.  Virotherapy-recruited PMN-MDSC infiltration of mesothelioma blocks antitumor CTL by IL-10-mediated dendritic cell suppression.

Authors:  Zhiwu Tan; Li Liu; Mei Sum Chiu; Ka-Wai Cheung; Chi Wing Yan; Zhe Yu; Boon Kiat Lee; Wan Liu; Kwan Man; Zhiwei Chen
Journal:  Oncoimmunology       Date:  2018-10-16       Impact factor: 8.110

4.  Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinoma.

Authors:  Kuo-Shyang Jeng; Chi-Juei Jeng; Wen-Juei Jeng; Chiung-Fang Chang; I-Shyan Sheen
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

Review 5.  Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract.

Authors:  Melanie C Langheinrich; Vera Schellerer; Aristotelis Perrakis; Clemens Lohmüller; Claus Schildberg; Elisabeth Naschberger; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

6.  Co-expression of CXCR4 and CD133 proteins is associated with poor prognosis in stage II-III colon cancer patients.

Authors:  Nian-Hua Zhang; Jie Li; Yin Li; Xin-Tao Zhang; Wen-Ting Liao; Jun-Yi Zhang; Rong Li; Rong-Cheng Luo
Journal:  Exp Ther Med       Date:  2012-03-27       Impact factor: 2.447

Review 7.  MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.

Authors:  Xiang Li; Jing Nie; Qian Mei; Wei-Dong Han
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

8.  The role of CXCL chemokine family in the development and progression of gastric cancer.

Authors:  Xuyan Chen; Renpin Chen; Ruifang Jin; Zhiming Huang
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

9.  Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer.

Authors:  Hongyan Yu; Xiangqi Meng; Jiangxue Wu; Changchuan Pan; Xiaofang Ying; Yi Zhou; Ranyi Liu; Wenlin Huang
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

10.  Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells.

Authors:  Deok-Soo Son; Syeda M Kabir; Yuanlin Dong; Eunsook Lee; Samuel E Adunyah
Journal:  J Inflamm (Lond)       Date:  2013-06-25       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.